Cargando…
Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance
INTRODUCTION: A long T(2) relaxation time can reflect oedema, and myocardial inflammation when combined with increased plasma troponin levels. Cardiovascular magnetic resonance (CMR) T(2) mapping therefore has potential to provide a key diagnostic and prognostic biomarkers. However, T(2) varies by s...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026458/ https://www.ncbi.nlm.nih.gov/pubmed/36935515 http://dx.doi.org/10.1186/s12968-023-00926-z |
_version_ | 1784909544862777344 |
---|---|
author | Topriceanu, Constantin-Cristian Fornasiero, Massimiliano Seo, Han Webber, Matthew Keenan, Kathryn E. Stupic, Karl F. Bruehl, Rüdiger Ittermann, Bernd Price, Kirsty McGrath, Louise Pang, Wenjie Hughes, Alun D. Nezafat, Reza Kellman, Peter Pierce, Iain Moon, James C. Captur, Gabriella |
author_facet | Topriceanu, Constantin-Cristian Fornasiero, Massimiliano Seo, Han Webber, Matthew Keenan, Kathryn E. Stupic, Karl F. Bruehl, Rüdiger Ittermann, Bernd Price, Kirsty McGrath, Louise Pang, Wenjie Hughes, Alun D. Nezafat, Reza Kellman, Peter Pierce, Iain Moon, James C. Captur, Gabriella |
author_sort | Topriceanu, Constantin-Cristian |
collection | PubMed |
description | INTRODUCTION: A long T(2) relaxation time can reflect oedema, and myocardial inflammation when combined with increased plasma troponin levels. Cardiovascular magnetic resonance (CMR) T(2) mapping therefore has potential to provide a key diagnostic and prognostic biomarkers. However, T(2) varies by scanner, software, and sequence, highlighting the need for standardization and for a quality assurance system for T(2) mapping in CMR. AIM: To fabricate and assess a phantom dedicated to the quality assurance of T(2) mapping in CMR. METHOD: A T(2) mapping phantom was manufactured to contain 9 T(1) and T(2) (T(1)|T(2)) tubes to mimic clinically relevant native and post-contrast T(2) in myocardium across the health to inflammation spectrum (i.e., 43–74 ms) and across both field strengths (1.5 and 3 T). We evaluated the phantom’s structural integrity, B(0) and B(1) uniformity using field maps, and temperature dependence. Baseline reference T(1)|T(2) were measured using inversion recovery gradient echo and single-echo spin echo (SE) sequences respectively, both with long repetition times (10 s). Long-term reproducibility of T(1)|T(2) was determined by repeated T(1)|T(2) mapping of the phantom at baseline and at 12 months. RESULTS: The phantom embodies 9 internal agarose-containing T(1)|T(2) tubes doped with nickel di-chloride (NiCl(2)) as the paramagnetic relaxation modifier to cover the clinically relevant spectrum of myocardial T(2). The tubes are surrounded by an agarose-gel matrix which is doped with NiCl(2) and packed with high-density polyethylene (HDPE) beads. All tubes at both field strengths, showed measurement errors up to ≤ 7.2 ms [< 14.7%] for estimated T(2) by balanced steady-state free precession T(2) mapping compared to reference SE T(2) with the exception of the post-contrast tube of ultra-low T(1) where the deviance was up to 16 ms [40.0%]. At 12 months, the phantom remained free of air bubbles, susceptibility, and off-resonance artifacts. The inclusion of HDPE beads effectively flattened the B(0) and B(1) magnetic fields in the imaged slice. Independent temperature dependency experiments over the 13–38 °C range confirmed the greater stability of shorter vs longer T(1)|T(2) tubes. Excellent long-term (12-month) reproducibility of measured T(1)|T(2) was demonstrated across both field strengths (all coefficients of variation < 1.38%). CONCLUSION: The T(2) mapping phantom demonstrates excellent structural integrity, B(0) and B(1) uniformity, and reproducibility of its internal tube T(1)|T(2) out to 1 year. This device may now be mass-produced to support the quality assurance of T(2) mapping in CMR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-023-00926-z. |
format | Online Article Text |
id | pubmed-10026458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100264582023-03-21 Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance Topriceanu, Constantin-Cristian Fornasiero, Massimiliano Seo, Han Webber, Matthew Keenan, Kathryn E. Stupic, Karl F. Bruehl, Rüdiger Ittermann, Bernd Price, Kirsty McGrath, Louise Pang, Wenjie Hughes, Alun D. Nezafat, Reza Kellman, Peter Pierce, Iain Moon, James C. Captur, Gabriella J Cardiovasc Magn Reson Research INTRODUCTION: A long T(2) relaxation time can reflect oedema, and myocardial inflammation when combined with increased plasma troponin levels. Cardiovascular magnetic resonance (CMR) T(2) mapping therefore has potential to provide a key diagnostic and prognostic biomarkers. However, T(2) varies by scanner, software, and sequence, highlighting the need for standardization and for a quality assurance system for T(2) mapping in CMR. AIM: To fabricate and assess a phantom dedicated to the quality assurance of T(2) mapping in CMR. METHOD: A T(2) mapping phantom was manufactured to contain 9 T(1) and T(2) (T(1)|T(2)) tubes to mimic clinically relevant native and post-contrast T(2) in myocardium across the health to inflammation spectrum (i.e., 43–74 ms) and across both field strengths (1.5 and 3 T). We evaluated the phantom’s structural integrity, B(0) and B(1) uniformity using field maps, and temperature dependence. Baseline reference T(1)|T(2) were measured using inversion recovery gradient echo and single-echo spin echo (SE) sequences respectively, both with long repetition times (10 s). Long-term reproducibility of T(1)|T(2) was determined by repeated T(1)|T(2) mapping of the phantom at baseline and at 12 months. RESULTS: The phantom embodies 9 internal agarose-containing T(1)|T(2) tubes doped with nickel di-chloride (NiCl(2)) as the paramagnetic relaxation modifier to cover the clinically relevant spectrum of myocardial T(2). The tubes are surrounded by an agarose-gel matrix which is doped with NiCl(2) and packed with high-density polyethylene (HDPE) beads. All tubes at both field strengths, showed measurement errors up to ≤ 7.2 ms [< 14.7%] for estimated T(2) by balanced steady-state free precession T(2) mapping compared to reference SE T(2) with the exception of the post-contrast tube of ultra-low T(1) where the deviance was up to 16 ms [40.0%]. At 12 months, the phantom remained free of air bubbles, susceptibility, and off-resonance artifacts. The inclusion of HDPE beads effectively flattened the B(0) and B(1) magnetic fields in the imaged slice. Independent temperature dependency experiments over the 13–38 °C range confirmed the greater stability of shorter vs longer T(1)|T(2) tubes. Excellent long-term (12-month) reproducibility of measured T(1)|T(2) was demonstrated across both field strengths (all coefficients of variation < 1.38%). CONCLUSION: The T(2) mapping phantom demonstrates excellent structural integrity, B(0) and B(1) uniformity, and reproducibility of its internal tube T(1)|T(2) out to 1 year. This device may now be mass-produced to support the quality assurance of T(2) mapping in CMR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-023-00926-z. BioMed Central 2023-03-20 /pmc/articles/PMC10026458/ /pubmed/36935515 http://dx.doi.org/10.1186/s12968-023-00926-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Topriceanu, Constantin-Cristian Fornasiero, Massimiliano Seo, Han Webber, Matthew Keenan, Kathryn E. Stupic, Karl F. Bruehl, Rüdiger Ittermann, Bernd Price, Kirsty McGrath, Louise Pang, Wenjie Hughes, Alun D. Nezafat, Reza Kellman, Peter Pierce, Iain Moon, James C. Captur, Gabriella Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance |
title | Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance |
title_full | Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance |
title_fullStr | Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance |
title_full_unstemmed | Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance |
title_short | Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance |
title_sort | developing a medical device-grade t(2) phantom optimized for myocardial t(2) mapping by cardiovascular magnetic resonance |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026458/ https://www.ncbi.nlm.nih.gov/pubmed/36935515 http://dx.doi.org/10.1186/s12968-023-00926-z |
work_keys_str_mv | AT topriceanuconstantincristian developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT fornasieromassimiliano developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT seohan developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT webbermatthew developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT keenankathryne developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT stupickarlf developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT bruehlrudiger developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT ittermannbernd developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT pricekirsty developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT mcgrathlouise developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT pangwenjie developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT hughesalund developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT nezafatreza developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT kellmanpeter developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT pierceiain developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT moonjamesc developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance AT capturgabriella developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance |